Results 71 to 80 of about 393,600 (259)

Doença Meningocócica Invasiva: Aplicação do Base Excess and Platelets Score numa Unidade de Cuidados Intensivos Pediátricos Portuguesa [PDF]

, 2015
INTRODUCTION: Meningococcal infection has a high mortality and morbidity. Recently a new prognostic scoring system was developed for paediatric invasive meningococcal disease, based on platelet count and base excess â base excess and platelets score ...
Carvalho, L, Dias, A, Dinis, A, Dionísio, T, Martins, L, Mação, P, Neves, JF, Pinto, C   +7 more
core   +1 more source

A Vaccine Against Group B Streptococcus: Recent Advances [PDF]

, 2020
Group B streptococcus (GBS) causes a high burden of neonatal and infant disease globally. Implementing a vaccine for pregnant women is a promising strategy to prevent neonatal and infant GBS disease and has been identified as a priority by the World ...
Carreras-Abad, C, Heath, PT, Le Doare, K, Ramkhelawon, L   +3 more
core   +2 more sources

Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England

Emerging Infectious Diseases, 2021
Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010–11 to 0.95/100,000 (530 cases) in 2018–19 and 0.74/100,000 in 2019–20 (419 cases). During national lockdown for the coronavirus disease pandemic (
S. Subbarao, H. Campbell, Sonia Ribeiro, S. Clark, J. Lucidarme, M. Ramsay, R. Borrow, S. Ladhani   +7 more
semanticscholar   +1 more source

Invasive meningococcal disease in the Veneto region of Italy: A capture-recapture analysis for assessing the effectiveness of an integrated surveillance system [PDF]

, 2017
open8noBACKGROUND: Epidemiology of Neisseria meningitidis has been changing since the introduction of universal vaccination programmes against meningococcal serogroup C (MenC) and meningococcal serogroup B (MenB) has now become dominant.
Baldo, Vincenzo, Baldovin, Tatjana, Bertoncello, Chiara, Cocchio, Silvia, Furlan, Patrizia, Lazzari, Roberta, Russo, Francesca, Saia, Mario   +7 more
core   +1 more source

Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease—Real-World Data Analysis Using the French National Claims Database (SNIIRAM)

Infectious Disease and Therapy, 2021
Objectives Invasive meningococcal disease (IMD) is an uncommon disease known for its acute phase mortality and long-term sequelae. The objective was to assess the impact of IMD on post-discharge mortality risk and dependence on the French state for ...
Jing Shen, S. Bouée, E. Aris, C. Emery, E. Beck   +4 more
semanticscholar   +1 more source

Expanding prevention of invasive meningococcal disease

Expert Review of Vaccines, 2009
Invasive meningococcal disease due to serogroups A, C, Y and W-135 is a serious, vaccine-preventable, worldwide public-health problem. Despite early treatment and advances in medical care, morbidity and mortality rates have essentially remained unchanged.
Stephen I, Pelton, Gregory P, Gilmet
openaire   +2 more sources

Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease

Infectious Disease and Therapy, 2021
Introduction Invasive meningococcal disease (IMD) is an uncommon, severe, life-threatening disease primarily affecting infants, with potential lifelong sequelae.
S. Scholz, M. Schwarz, E. Beck, K. Meszaros, Melanie K Schneider, B. Ultsch, W. Greiner   +6 more
semanticscholar   +1 more source

The Epidemiology of Invasive Meningococcal Disease in the Kingdom of Saudi Arabia: A Narrative Review with Updated Analysis

Infectious Disease and Therapy, 2021
Reducing invasive meningococcal disease (IMD) through MenACWY immunization is a critical healthcare strategy in the Kingdom of Saudi Arabia (KSA). Robust IMD surveillance is essential to help assess the need for additional immunization initiatives in ...
S. Badur, Mona Al Dabbagh, A. Shibl, F. Farahat, S. Öztürk, D. Saha, M. Khalaf   +6 more
semanticscholar   +1 more source

A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine

Infectious Disease and Therapy, 2021
The quadrivalent A, C, W and Y meningococcal vaccine conjugated to nontoxic mutant of diphtheria toxin (MenACWY-CRM) has been licensed since 2010 for the prevention of invasive meningococcal disease (IMD), an uncommon but life-threatening condition. Here,
Yara Ruiz García, V. Abitbol, M. Pellegrini, R. Bekkat-Berkani, L. Soumahoro   +4 more
semanticscholar   +1 more source

Control of invasive meningococcal disease

International Journal of Evidence-Based Healthcare, 2016
Neisseria meningitidis still leads to deaths and severe disability in children, adolescents and adults. Six different capsular groups of N. meningitidis cause invasive meningococcal disease in the form of meningitis and septicaemia in humans. Although conjugate meningococcal vaccines have been developed to provide protection against four of the ...
Marshall, H, Wang, B, Wesselingh, S, Snape, M, Pollard, A   +4 more
openaire   +3 more sources